Eiken Chemical Co., Ltd. – Trademark Portfolio

Entity Type: 03

Eiken Chemical Co., Ltd. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 14 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include 'EIKEN'. The owner is based in Bunkyo-ku, Tokyo.

No. 1-33-8, Hongo

Bunkyo-ku, Tokyo , JP

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Eiken Chemical Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (14 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Eiken Chemical Co., Ltd. have?

Eiken Chemical Co., Ltd. has 16 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 12 cancelled.

What trademark classes does Eiken Chemical Co., Ltd. file in?

Eiken Chemical Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Eiken Chemical Co., Ltd.'s most well-known trademarks?

Eiken Chemical Co., Ltd.'s registered trademark portfolio includes well-known marks such as 'EIKEN'. These are among 1 currently registered trademark in the portfolio.

What is Eiken Chemical Co., Ltd.'s trademark registration success rate?

Eiken Chemical Co., Ltd. has a 6% trademark registration rate, with 1 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.